Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
AbSci Corporation
AI Executive Summary
AI-powered analysis of 8-K filing content
AbSci Corporation held its Annual Meeting of Stockholders on June 4, 2026, where shareholders elected Prof. Sir Menelas Pangalos, Ph.D., and Daniel Rabinovitsj as Class II board members to serve until the 2029 Annual Meeting. This routine governance event reflects the company's ongoing leadership structure as it pursues growth in the biotech industry.
Key Takeaways
Prof. Sir Menelas Pangalos, Ph.D., and Daniel Rabinovitsj were elected as Class II directors with three-year terms expiring at the 2029 Annual Meeting
155,447,428 shares were outstanding and eligible to vote as of the April 7, 2026 record date
1 more takeaway
Related Filings (1)
1 more filing from AbSci Corporation in the last 90 days